Compositions Comprising Polypeptides having Xylanase Activity and Polypeptides having Arabinofuronosidase Activity

A liquid composition comprising a polypeptide having arabinofuranosidase activity and one or more formulating agents, wherein:

• (i) the polypeptide having arabinofuranosidase activity has at least 80% sequence identity to the polypeptide of SEQ ID NO:
• 27;
• and
• (ii) the polypeptide having arabinofuranosidase activity is dosed in a range of 0.01-200 mg arabinofuranosidase protein per kg substrate (ppm).

A liquid composition comprising a GH62 polypeptide having arabinofuranosidase activity, a GH10 or GH11 polypeptide having xylanase activity, and one or more formulating agents, wherein:

• (i) the polypeptide having arabinofuranosidase activity has at least 80% sequence identity to the polypeptide of SEQ ID NO:
• 27;
• and
• (ii) the ratio of the GH10 or GH11 xylanase to GH62 arabinofuranosidase is in the range of 50:1 to 1:50 xylanase:arabinofuranosidase.

A liquid composition comprising a GH62 polypeptide having arabinofuranosidase activity, a GH10 or GH11 polypeptide having xylanase activity, and one or more formulating agents, wherein:

• (i) the polypeptide having arabinofuranosidase activity has at least 80% sequence identity to the polypeptide of SEQ ID NO:
• 27 and the polypeptide having arabinofuranosidase activity is dosed in a range of 0.01-200 mg arabinofuranosidase protein per kg substrate (ppm);
• (ii) the one or more GH10 or GH11 polypeptides is dosed in a range of 0.01-200 mg xylanase protein per kg substrate (ppm);
• and
• (ii) the ratio of the GH10 or GH11 xylanase to GH62 arabinofuranosidase is in the range of 50:1 to 1:50 xylanase:arabinofuranosidase.